CHPJ Articles
Showing 49–60 of 166 resultsSorted by latest
-
Waiting for new medicines in Canada, Europe and the United States 2016-2021
$0.00 Add to cart -
Access to new medicines in Canada 2016-2021: Federal-provincial public drug programs and private sector drug plans
$0.00 Add to cart -
The PMPRB: Where Are We Now and What’s Next?
$0.00 Add to cart -
Bringing value to healthcare through ambulatory services
$0.00 Add to cart -
Analysis of interventions addressing the nutrition status of seniors in Ontario
$0.00 Add to cart -
A Dollar a Day May Keep the Doctor Away: Putting Spending on Food and Healthcare on a Scale
$0.00 Add to cart -
Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19
$0.00 Add to cart -
Champ d’exercice de la pharmacie et accès aux traitements par agonistes opioïdes (TAO) au Canada après la COVID-19
$0.00 Add to cart -
Why would Canada have the longest wait times for an Alzheimer’s treatment among the G7 countries?
$0.00 Add to cart -
Rogue Regulator: PMPRB’s false narrative is driving dangerous drug price controls
$0.00 Add to cart -
Availability and Accessibility of Essential Drugs for Rare Disorders in Canada
$0.00 Add to cart -
Canada’s COVID-19 Vaccine Procurement Strategy: Comparisons with the United Kingdom and Israel
$0.00 Add to cart